Pharmeca.cz

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Cipla Europe NV, against the decision of the State Institute for Drug Control from 7. 10. 2021, under the no.: SUKLS196911/2021:

• the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelants Merck Europe B.V. and Teva Pharmaceuticals CR, s.r.o., against the decision of the State Institute for Drug Control from 24. 3. 2021, under the no. SUKLS81849/2014:

• the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of Health Insurance companies, against the decision of the State Institute for Drug Control from 11. 3. 2020, under the no.: SUKLS68059/2017:

• the operative parts 3 and 5 of the decision are reversed and the proceedings are terminated
• the remainder of the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of Health Insurance companies, against the decision of the State Institute for Drug Control from 11. 3. 2020, under the no.: SUKLS68059/2017:

• the operative parts 13b), 14b), 15b), 16b), 17b), 18b), 19b), 20b), 21b), 22b), 23b), 24b), 25b), 26b), 27b), 28b), 29b), 30b), 31b), 32b), 39b), 40b), 41b), 42b), 49b), 50b), 51b), 52b), 53b), 54b), 55b), 56b), 57b), 58b), 59b), 60b), 61b), 62b), 63b), 64b), 65b), 66b) of the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal  
  
• the remainder of the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of Health Insurance Companies, against the decision of the State Institute for Drug Control from 8. 10. 2019, under the no. SUKLS204192/2019:

• the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelants Dr. Falk Pharma GmbH and Tillotts Pharma GmbH, against the decision of the State Institute for Drug Control from 10. 12. 2019, under the no.: SUKLS231130/2017:

• the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

Remonstrance of the health insurance companies of 19 July 2021 against the decision of the Minister of Health of 30 June 2021, under the no. MZDR 23415/2021-3/PRO, according to article 152 paragraph 6 letter b) of the Administrative Code is dismissed.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of Health Insurance Companies, against the decision of the State Institute for Drug Control from 27. 9. 2019, under the no. SUKLS231935/2019:

• the operative part 2 of the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.

More information: MZCR.cz.